Garretson Talks Biosimilars for ACI Summit
New York, NY
Shook, Hardy & Bacon Intellectual Property Litigation Partner John Garretson co-presents a panel discussion titled “Incorporating Inter Partes Review and New USPTO Procedures into Branded and Biosimilar Litigation Strategies” during ACI’s 6th Annual Summit on Biosimilars on June 2, 2015.
Among other things, the presentation will cover fundamentals of U.S. Patent and Trade Office (USPTO) post-grant procedures in the biosimilars space, considerations for patents filed after the effective date of the America Invents Act and the benefits of inter partes review (IPR) in the biosimilars context. Shook is a co-sponsor of the event.
Among other things, the presentation will cover fundamentals of U.S. Patent and Trade Office (USPTO) post-grant procedures in the biosimilars space, considerations for patents filed after the effective date of the America Invents Act and the benefits of inter partes review (IPR) in the biosimilars context. Shook is a co-sponsor of the event.
